analysts and calls -- Morgan Stanley Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : analysts and calls -- Morgan Stanley

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (25)	5/16/2003 12:19:29 PM
From: JFitnich	of 31

To all, Harr is a big MDCO supporter and I think that bias colors his decision on MLNM regarding Integrilin at the very least. He believes that Angiomax is going to continue to take measurable share from the 2b/3a drugs going forward. I'm not saying he isn't a good analyst. He was on mark with Scios, a stock I did well with following his comments. He followed it before the majority of the other analysts on the street. He may be conservative regarding Velcade or he may just be negative re: MLNM because of MDCO. JF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next